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The oral dosages formulations from Pothomorphe umbellata
(Piperaceae) can only be therapeutically evaluated after
establishing 4-nerolidylcatechol (4-NRC) pharmacokinetic profile
in plasma. For that purpose, a unique analytical method validation
using HPLC-UV detection was developed for analysis of rat plasma
samples. The animals received 10 mg/kg b.w. of 4-NRC i.v..
Analytical conditions were set with C18 column, methanol:
acetonitrile: water (62:20:18) as mobile phase, and a flow rate of
1.6 mL/min. The assay was linear from 1.0 - 80.0 mcg/mL. The
recovery procedure was performed by liquid-liquid extraction
showing quantitative extraction (106.4±8.7%). Limit of
Quantification (LOQ) was found to be 1.0 mcg/mL. Interassay
precision and accuracy ranged from values of 14.4-3.0% and 24.0–
0.2%, respectively. Recovery after liquid-liquid extraction was found
to be 106.5 ± 3%. The method is simple and reliable with total run
time of less than 15 min.
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In recent years, there has been a growing interest in
the compound 4-nerolidylcatechol found in some
Piperaceae shrubs. 4-Nerolidylcatechol (4-NRC) is the
major secondary metabolite from Pothomorphe peltata
and Pothomorphe umbellata traditionally used for
treatment of hepatic disorders on Brazilian Southwest and
Amazon area, respectively (Silva, 1926; Di Stasi et al.,
1994). Pharmacological studies involving quenching of lipid
peroxidation have shown remarkable antioxidant activity
for 4-NRC when compared with a-tocopherol (Barros et
al., 1996; Desmarchelier et al., 1997). Corroborating these
studies, 4-NRC 0.1% (w/w) was added to topic skin
formulations showing UV protection and percutaneous
absorption (Röpke et al., 2002). Additionally, crude
ethanolic extracts of P. umbellata leaves have
demonstrated antimalarial activity (Amorim et al., 1988)
and absence of mutagenic effects in Salmonella
typhimurium  (Felzenszwalb  et al., 1987) and on
micronuclear erythrocytes (Barros  et al., 2001).
Furthermore, dimmers of 4-NRC have also shown anti-
HIV activity (Gustafson et al., 1992).
However, for preclinical studies it is essential to
establish pharmacokinetic properties (De Smet, Rouwers,
1997; Hamburguer, Hostettmann, 1991) and assess
pharmacological levels associated with the safety and
efficacy of the drug. Therefore, a sensitive and reliable
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analytical method must be developed to assess such
properties for the compound of interest.
The chemical structure of 4-nerolidylcatechol (1)
was first described in a hexane extract (Kijoa et al., 1980),
which also contained various phenylpropanoids such as
apiol (Silva, Baver, 1972), dilapiol (Bernard, Tieli, 1978) and
the sesquiterpene nerolidol. Since then, several other
substances were identified in more polar extracts. These
include some flavonoids, lignans (Bastos, 1998) and
dimmers (peltatols A, B and C) of the prenylated catechol
(Gustafson et al., 1992).
Several analytical methods for phenols, catechols
and polyphenols molecules are available. However,
physicochemical properties of catechol-containing
molecules show predominant water solubility (i.e.
polyphenols) instead of liposolubility (log P=6.03), as
depicted for 4-NRC (Freitas, 1999). Therefore, in response
to the need for a sensitive method to quantify 4-NRC, we
examined methods using liquid chromatography coupled to
electrochemical detection (Cai et al., 1999; Stremetzne,
Jaehde, Schumack, 1997; Holmes, Eisenhofer, Goldstein,
1994; Lunte, 1987; El-Shafae, El-Domiaty, 2001) and
ultraviolet detection (Romanova et al., 2000; Rouseff et
al., 1992; Ruperez et al., 1999; Castagnetta et al., 1992),
as primarily options. Such methods generally show suitable
sensitivity for plasma samples, even when compared to
more selective ones (Lee et al., 1993; Stecher et al.,
2001). In addition, those equipments are easily handled and
available in most laboratories.
Thus, the aim of this work was to develop an HPLC-
UV method for preliminary quantification and assessment
of biological interferences of 4-nerolidylcatechol in rat
plasma after iv dosing.
MATERIAL AND METHODS
Materials and reagents
HPLC grade acetonitrile, methanol and hexane were
purchased from Fisher Scientific (Pittsburgh, PA, USA),
filtered under vacuum through 0.45 mm Teflon filter
(Millipore, Bedford, MA, USA) and degassed under
ultrassonication (15 min/L). 2, [6]-Di-tert-butyl-p-cresol
(BHT) was purchased from Sigma (St. Louis, MO, USA).
Male Wistar rats (275-325g) were purchased from Facul-
dade de Medicina Veterinária e Zootecnia – Universida-
de de São Paulo. Preparative column chromatography
under vacuum and preparative radial thin-layer
chromatography (Chromatotron™ model 8924)
experiments used Silica gel 60 H (Merck, 63 - 210 mm)




A reverse phase column Zorbax SB C18, 4.6 X 150
mm, 5-mm (Chromatography Specialties, Mississauga,
ON, Canada) with an HPLC Constametric 3200 system
was coupled to UV detector (1049A WATERS) at 282 nm.
Auto-sampler interface was accomplished by HP 3396
series III with a Reodyne injector loop (20 mL). Aliquots
were injected and eluted with methanol-acetonitrile-water
(62:20:18, v/v/v) as isocratic mobile phase mixture. Flow
rate was set at 1.6 mL/min.
Purification of 4-nerolydilcatechol and its extraction
from plasma
Leaves of Pothomorphe umbellata were collected
in February 1998 at Piperaceae’s garden of Instituto de
Química, Universidade de São Paulo. A voucher specimen
(Kato-0363) was identified by Dra. Inês Cordeiro (Univer-
sidade Federal do Paraná - Curitiba) and deposited in the
herbarium of Instituto de Botânica (Secretaria do Meio
Ambiente do Estado de São Paulo).
Leaves (1 kg) were dried, milled and exhaustively
extracted with MeOH yielding 184.2 g of crude extract
after solvent evaporation. The leaves extract (180.0 g)
was resuspended in MeOH:H2O (8:2) and filtered through
a celite column (10 x 10 cm) to remove pigments and
lipophilic interferents from the matrix. Solvent evaporation
yielded a solid residue (84.1 g). Next, a small aliquot (10
g) was applied to a flash-filtering column on silica gel 60H
(10 x 10 cm) using CHCl3 as eluent. The CHCl3 extract
residue (6.1 g) was solubilized in hexane (20 mL),
fractionated (6x) and submitted to preparative radial thin-
layer chromatography (PR-TLC, 110.0 x 4.0 mm).
Chromatographic conditions were flow rate of 8.0 mL/min
and eluotropic gradient of hexane: CH2Cl2: methanol
(10:5:1 up to 0:5:1) during 94 min. Separation of
constituents was monitored with a UV lamp at 254 nm.
Sample fractions were compared with authentic standard
sample and submitted to final purification at PR-TLC
(hexane:ethylacetate 80:20; 8.0 mL/min). Evaporation of
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the residue yielded a pale yellow oil (1.2 g) chemically
identified by 1H and 13C NMR, as 4-NRC. Its purity was
not lower than 96% in analytical chromatographic
conditions described herein.
Root extract standardization
Pothomorphe umbellata roots were cleaned, dried,
milled (822.5 g) and percolated in 60% ethanol (18 L) as
directed by Method A of Pharmacopeia dos Estados Uni-
dos do Brasil (Silva, 1959). The pharmacopoeical
preparation was submitted to solvent evaporation yielding
a dried crude extract (78.5 g/9.5%). Standardization was
carried out using five accurate weighted (0.5 mg/mL)
crude extract replicates. Quantification was measured
against pure 4-NRC standard solutions in methanol.
Results showed 21.5 ± 3.3% of 4-NRC contents.
4-Nerolidylcatechol solutions and calibration standards
4-NRC stock solution was prepared in methanol to
achieve 100.0 µg/mL, as a final concentration. Next, work
solutions were prepared to give five standard points in
mobile phase that were stored at –70 oC. All five work
stock solutions were set in a manner such that the same
aliquot amount was taken and spiked in plasma matrix
(e.g.100 µL work solution/1 mL plasma). Subsequently,
calibration standards were prepared in pooled plasma
samples spiked with known amounts of the work solutions
to give final concentrations of 1.0; 3.0; 20.0; 50.0;
80.00 µg/mL. Aliquots of 250 µL spiked plasma samples
were transferred to borosilicate tubes using micropipettes
(Gilson, USA), capped with PE plugs (Fischer Scientific,
USA) and kept at – 17 oC. Thaw of samples were carry
out when necessary to run daily calibration curves.
Plasma sample preparation
The 4-NRC extraction procedure from plasma
samples was prepared in media containing BHT (8.0 mg/L)
as antioxidant agent. 1 mL of methanol/ethanol (1:1)
was added to 250 µL of plasma, followed by vortex mixing
(1 minute). Next, water (500 µL) and hexane (2 mL) were
added. Subsequent to sealing the tubes, horizontal agitation
was performed (3 x 20 min). Fresh hexane portions were
added three times followed by centrifugation. The upper
(hexane) layers were removed after “snap freezing”
technique under liquid nitrogen and transferred to clean
borosilicate tubes. After gathering it was evaporated under
N2 stream. The residue was ressuspended in 250 µL of
methanol/water (85:15). Solutions were covered with
aluminum foil and left at room temperature for 10 min and
20 µL were injected in HPLC system.
Validation results
The method was validated for linearity, selectivity,
recovery, accuracy, precision and stability in plasma
samples. The analyte retention time in plasma and crude
plant extract samples was found to be 6.3 (±0,23) min and
the total run time was set at 14.5 min.
• Assessment of Linearity and Selectivity
Linearity over dynamic range (1.0 to 80.0 µg/mL)
was assessed by duplicate analysis of five points, during 3-
day period. 4-NRC quantification was measured by peak
height response and derived from a standard curve
performed in both plasma and methanol matrix (crude
extract quantification). Results based on average
correlation coefficient-R2 showed great linearity
(0.994±0.002).
Selectivity was determined by analyzing blank plas-
ma samples from four different Wistar rats. Suitable 4-
NRC separation from plasma constituents was shown and
no coincident interferences to analyte retention time were
detected.
• Recovery of 4-nerolidylcatechol
Following plasma spiking, the amount of 4-NRC
recovered was estimated at all five-point calibration
standards and analyzed on three different days (Table I).
Pooled plasma samples were prepared based on standard
technique addition. Six estimations were made on each
calibration standard. Recovery was calculated as the ratio
TABLE I - Summary for recovery of added 4-nerolidylcatechol
4-NRC added concentration in plasma Average concentration Coefficient of Recovery
(mg/mL) (N=6) ± SD Variation (%) (%)
1 1.06±0.134 12.66 105.8
3 3.57±0.228 6.38 119.0
20 18.31±1.723 9.41 91.6
50 53.94±3.373 6.25 107.9
80 85.86±8.210 9.56 107.3
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between peak height response of extracted and not
extracted analyte (standard work solutions added to
extracted blank plasma) from each plasma sample. The
value is expressed as the ratio between average experi-
mental and nominal concentration of the analyte, multiplied
by 100%. The results summarized in Table I indicate
quantitative average recovery of 106.4 ± 8.7% in plasma.
• Accuracy and precision
Analytical method accuracy and precision were
assessed by daily duplicate analysis of samples containing
known amounts of 4-nerolidylcatechol (1.0 up to 80.0 µg/mL),
during 3-day period. These samples were prepared by the
standard addition technique. Spiked plasma samples were
stored at -80 oC, fractionated as single aliquots (250 µL)
throughout the period of experiment.
The limit of detection (LOD) was determined using
four pooled blank plasma sample spiked with work
standard solutions. LOQ was set for the lowest
concentration standard curve measured with acceptable
accuracy and precision (SD±25.0%). LOQ was inferred
as three times the LOD, which was found to be 1.0 µg/mL.
Interassay precision was determined by coefficient
of variation (CV) obtained by the ratio between standard
deviation and average mean of replicates, during 3-day
validation. Sample precision was found to be in the range
of 14.4-3.0%, as detailed on Table II. Intrassay precision
was surely lower than interassay precision and not shown
here.
Accuracy was assessed by the ratio between ave-
rage relative error around the mean and added concen-
tration, during 3-day validation experiments. The results
are summarized in Table II. The accuracy relative error
found for LOQ was 24% while it was between 19.7–0.2%
for 3-80.0 µg/mL concentration range.
• Assessment of stability under freeze/thaw conditions
Storage conditions were evaluated by freeze-thaw
stability comparing the 4-NRC amount found in samples
that had been frozen (-80 oC) and thawed (20 oC) three
times with fresh plasma samples. Each freeze-thaw cycle
duration was no less than 12 h. The stability maintained for
at least 4 weeks, based on chromatographic evidence
indicating no apparent deterioration, which means not more
than 2.9% difference on the amount of 4-NRC. These
TABLE II - Summary of interassay precision and accuracy of calibration curves during 3-day
R2 slope intercept 4-NRC spiked plasma concentrations (μg/mL)
1. 0 3. 0 20. 0 50. 0 80. 0
Mean (n=9) 0. 994 4213. 47 1628.58 1. 24 3.59 17. 89 50. 87 80. 13
SD interday 0. 002 368. 56 1676.94 17.80 0.35 1.86 3. 24 2. 39
Precision* 0. 22% 8. 75% —— 14.36% 9.75% 10.38% 6. 37% 2. 98%
Accuracy** —- —— —— 24.0% 19.67% 10.55% 1.74% 0.16%
* CV (%)- standard deviation/mean x 100%; ** Error %- (found concentration – nominal concentration)/nominal
concentration x 100%
FIGURE 1 - Typical chromatogram of blank plasma (C)
and spiked plasma with 4-nerolidylcatechol at 1,0 μg/mL de
4-NRC (B) and 3,0 μg/mL de 4-NRC (A).
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results indicate 4-NRC is stable in rat plasma after three
freeze-thaw cycles.
Pharmacokinetic data applications
4-NRC parenteral solution (2.5 mg/mL) was
prepared in 30% hydroxypropyl-β-cyclodextrin (Sigma, St
Louis, USA) and filtered (Millipore , 0.45 μm). The drug
was administered as i.v. bolus (10 mg/kg) through
dissected femoral vein (27G needle), while animal body
conditions (temperature and plasma volume) were
maintained under control (warming paddle and 5 U.I.
heparin solution reposition). Blood samples were collected
after distal and proximal isolation of carotid artery portion
(thread silk, 5.O.1), following its canulation with a catheter
(FEP tubing, 22 G). Sample collection (eight time points;
300 μL) was set at the following schedule time: 0.0; 2.5;
5.0; 7.5; 10.0; 15.0; 17.5; 20.0; 30.0; 45.0; 60.0; 70.0 min
on heparinized eppendorf tubes. Blood samples were
centrifuged (3000 rpm/2 min) and plasma was stored
(–80 oC) until analysis. The 4-NRC plasma concentration
obtained at each time point is presented in Figure 2.
DISCUSSION AND CONCLUSION
A simple HPLC-UV method for analysis of 4-
nerolydilcatechol in plasma was developed. This method is
based on liquid-liquid extraction and an isocratic reversed-
phase HPLC analysis with a total run time of less than 15
min, a run time frequently targeted with ultraviolet
detection.
The accuracy maximum relative error for LOQ was
set at ± 25%. It can be partially justified by the absence of
a suitable internal standard and also, by the 4-NRC high
affinity to blood cells. This later assertion is based on
additional evaluation of some bench-top conditions.
Preliminary studies reinforce suspicions of high erythrocyte
partition coefficient based on a high liposolubility of 4-NRC
(Freitas, 1999). The assay procedure was based on literature
(Boulton, Walle, Walle, 1999). Blood samples were spiked
with 4-NRC (50 mg/mL) and quantified on triplicate.
Analytical conditions were simulated keeping blood samples
at controlled temperature (0 oC and 37 oC) and incubation
time (0.0 and 60.0 min). Photoxidation during bench-top and
in-process assays, including auto-sampler injection were
prevented by aluminum foil protection. Results showed that
blood aliquots, which were maintained at 37 oC/1 h, yielded
lower 4-NRC average recovery (66.9 %) in plasma when
compared to samples immediately extracted or when kept
under refrigeration (0 oC/1 h). Similar findings are frequently
seen on other lipophilic drug profiles (Derendorf et al., 1984;
Derendorf, Garret, 1983). Several methodological conditions
as sample concentration, pH, temperature and protein
binding (Boulton, Walle, Walle, 1999) are also important
variables, but not yet controlled here. Therefore, further
developments on this issue are to be carried out.
As a final point, the analytical method presented
herein can be applied as an important approach to
standardization of Pothomorphe umbellata roots extracts,
previously to the determination of 4-NRC plasma level
during pre-clinical phase trials. Additionally, this method
FIGURE 2 - Plasma concentration level of 4-NRC following iv bolus dosing of 10 mg/kg (2.5 mg/mL in 30%
hydroxypropyl-β-cyclodextrin).
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can be applied to preliminary pharmacokinetic studies in
animal model leading to an important overview of the drug
distribution and elimination process. Kinetica 2000™
software was used and Vd and Kel parameters were
calculated. The values found after i.v. dosing (100 mg/kg)
were 0.5 L and 0.11 min, respectively, meaning a large
distribution and rapid elimination rate, as expected for
highly lipophilic drugs, as for 4-NRC.
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RESUMO
Quantificação de 4-nerolidilcatecol de
Pothomorphe umbellata (Piperaceae) em amostras
de plasma de rato por CLAE-UV
O 4-nerolidilcatecol representa o metabólito secundá-
rio mais abundante de Pothomorphe umbellata
(Piperaceae), cujo uso terapêutico deve ser fundamen-
tado após a caracterização farmacocinética do mesmo
(4-nerolidicatecol). Os níveis séricos de animais trata-
dos com 10 mg/kg do fármaco i.v. foram avaliados por
validação analítica em CLAE-UV. As condições
cromatográficas empregadas foram fase móvel de
acetonitrila:metanol:água (62:20:18), coluna RP-18,
fluxo de 1,6 mL/min e detector UV em 282 nm, com tempo
total de corrida inferior a 15 minutos. Observou-se
linearidade do 4-NRC em plasmas na faixa de 1,0 a 80,0
mcg/mL, com valores de precisão e exatidão entre 14,4-
3,0% e 24,0–0,2%, respectivamente. O procedimento de
extração líquido–líquido apresentou reprodutível e com
recuperação quantitativa (106,5%±3,0%).
UNITERMOS: 4-Nerolidilcatecol. Pothomorphe
umbellata. CLAE-UV. Extração líquido-líquido.
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